Keywords: celgene, reports, data, trials, revlimid, mm, nhl

Celgene reports data from trials of Revlimid in MM, NHL and MDS at 11th annual EHA

Article | 26 June 2006

Print This

The 11th annual congress of the European Hematology Association, held this month in Amsterdam, Holland, saw presentations from some of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in